Blog - Page 687 of 5690 - QualityStocks

WednesdayJul 05, 2023 10:48 am

QualityStocksNewsBreaks – Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) (FSE: HF2) Affirms Exceptional Quality of Graphite Material at Ruby Property

Reflex (CSE:RFLX) (OTCQB: RFLXF) (FSE: HF2) today announced that purities of 99.999% graphitic carbon (“Cg”) were obtained from preliminary metallurgical studies testing the purification of the material sourced from its flagship Ruby Graphite Project located near Dillon, Montana, USA. According to the update, graphite concentrations of 99.999% Cg purity were achieved solely using a conventional thermal purification process. “Today marks another major milestone for Reflex. The achievement of 99.999% Cg from purification testing - without any optimization - only reaffirms our belief in the exceptional quality of the graphite material hosted on our Ruby property,” said Reflex CEO Paul Gorman.…

WednesdayJul 05, 2023 10:30 am

Freight Technologies Inc. (NASDAQ: FRGT) Contract Renewal Indicates Company’s Success in Supporting International Transports

Freight Technologies (aka Fr8Tech) has developed a technology solution that uses machine learning and artificial intelligence (“AI”) to help shipping and freighting companies optimize product transports and avoid costly errors Fr8Tech recently announced that one of its top clients, multinational insulation manufacturing company K-FLEX de México SA de CV, renewed its contract for using Fr8Tech’s core tech solution, Fr8App K-FLEX cited Fr8App’s benefits to the company during the difficult COVID-19 pandemic period and beyond as K-FLEX expanded its operations and approaches $1 billion in annual revenues Fr8Tech is continuing to expand its technology frontiers with the establishment of a dedicated…

WednesdayJul 05, 2023 9:00 am

The 2023 Alternative Products Expo, Dallas Chapter – “Everything Counterculture Under One Roof”

ZJ Events is proud to announce the third leg of its four-part Alternative Products Expo – the Dallas Chapter – that will be held at the Kay Bailey Hutchison Convention Center Dallas. The expo, which promises to be the ultimate event for anyone in the counterculture industry, will serve as a melting pot for everything counterculture, with featured products including CBD, mushrooms, nicotine replacement, dietary supplements, and nootropics, among others. The event will be held from July 13-15, bringing together hundreds of leading brands such as 3Chi, Mellow Fellow, and Cali Kulture. The event will also offer a platform where…

MondayJul 03, 2023 12:18 pm

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Adds Greater Flexibility, Accelerated Technology Development Capability to NVIDIA Omniverse Platform

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, recently integrated its Vista-X120 Plus lidar into DRIVE Sim, an end-to-end simulation application built on the NVIDIA Omniverse platform. “The NVIDIA Omniverse platform enables real-time simulation and 3D visualization for metaverse applications by providing a shared virtual environment where users can collaborate to engineer real-world scenarios… Cepton was one of the first companies to demonstrate a 360°-coverage, dual-range lidar simulation that detected long-range obstacles and eliminated near-range blind spots. The addition of the Vista-X120 Plus into the Omniverse builds upon previous integrations to give AV developers access…

MondayJul 03, 2023 12:01 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-Processed Formulation Results in Higher Concentration, Delivery of Estrogen Hormone than Control

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently completed its animal study HOR-A22-1, which showed that the company’s patented DehydraTECH(TM) technology platform significantly enhanced the oral delivery of the estrogen hormone estradiol. “The study found that the DehydraTECH-estradiol composition resulted in a maximum concentration in the bloodstream (‘Cmax’) of 5.65 ng/mL, which was approximately 900% higher than the control formulation’s Cmax (0.63 ng/mL). Additionally, the use of the DehydraTECH-formulation resulted in a 2,000% increase in the levels of the estrone metabolite, also measured using the Cmax parameter: DehydraTECH-estradiol resulted in a Cmax of 6.49 ng/mL…

MondayJul 03, 2023 11:30 am

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Well Positioned to Move next NanoAb Candidates into Clinical Application

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, recently signed an exclusive worldwide license agreement to develop and commercialize VHH antibodies (“NanoAbs”) that target Interleukin-17 (“IL-17”). “The license agreement is part of a broad-based collaboration with the Max Planck Society and the University Medical Center Göttingen (‘UMG’). The NanoAbs will be targeted toward the treatment of several relevant indications, including, but not limited to, psoriasis and psoriatic arthritis. BiondVax’s collaboration with the Max Planck Institute for Multidisciplinary Sciences and UMG, both based in Germany,…

MondayJul 03, 2023 11:23 am

QualityStocksNewsBreaks – GolfLync Inc. Affirms Status as Go-to ‘Social Network for Golfers’

GolfLync is the company behind the GolfLync app – a social network for matching golf games and players. “GolfLync just affirmed its status as the go-to ‘social network for golfers’ with over 200 5-star ratings on the Apple App Store. The ratings reflect the warm reception the app has received thus far, the level of thoughtfulness and detail that went into its development, and the real user value that GolfLync delivers to the growing community of golf enthusiasts around the country. Ratings are the way users find the top apps in a category, and GolfLync is significantly higher than the…

MondayJul 03, 2023 10:30 am

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Advancing the Use of AI to Power Financial Solutions

FEXD acknowledges the recent big data boom that has introduced tech-driven solutions in the current financial services space AI, through its many forms, has proven to be a viable technology to integrate into the financial service space, a development that FEXD recognizes and welcomes Through its focus on the benefits of AI, the company is pushing its adoption while also pushing the conversation forward It is doing so while also exploring ways it can further develop this technology to address unmet mobile money needs, both in developing and industrialized countries and markets Fintech Ecosystem Development (NASDAQ: FEXD), a special purpose…

MondayJul 03, 2023 9:45 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Set to Control North America’s REE Supply Chain Amid Call For Economically and Environmentally Sound Approach

Ford Motor Co. recently announced a $9.2 billion government loan for constructing three battery factories in the U.S. This is seen as a move that seeks to stir the growth of domestic EV battery manufacturing in the country in response to the growing demand for green technologies Ucore recognizes this demand, and through its transformative commercial-ready technology, RapidSX(TM), it looks to satisfy it and take control of the North American REE supply chain The company is well aware of the developments within its industry and is well positioned to take advantage of them and become the undisputed leader in the…

MondayJul 03, 2023 9:00 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Expands Offering to Include Boutique End-to-End CDMO Services

BiondVax’s CDMO services allow the company to partner with pharmaceutical companies to provide contract-based drug development and manufacturing services BiondVax showcased its boutique end-to-end CDMO offering at the annual Biomed Conference in Tel Aviv in May BiondVax’s cGMP biologics manufacturing facility in Jerusalem is fully equipped with state-of-the-art CDMO capabilities The expansion of CDMO services will augment revenue and expand pharma contacts while still maintaining BiondVax’s core focus of NanoAb therapies for significant indications like COVID-19, psoriasis, asthma, and more BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment…

Site Search

Company Search